Riggs Asset Managment Co. Inc. Agios Pharmaceuticals, Inc. Transaction History
Riggs Asset Managment Co. Inc.
- $321 Million
- Q1 2025
A detailed history of Riggs Asset Managment Co. Inc. transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Riggs Asset Managment Co. Inc. holds 41 shares of AGIO stock, worth $1,640. This represents 0.0% of its overall portfolio holdings.
Number of Shares
41
Previous 41
-0.0%
Holding current value
$1,640
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding AGIO
# of Institutions
235Shares Held
59.8MCall Options Held
323KPut Options Held
367K-
Farallon Capital Management LLC San Francisco, CA5.7MShares$228 Million0.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.6MShares$224 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$194 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.52MShares$141 Million2.39% of portfolio
-
State Street Corp Boston, MA2.45MShares$98 Million0.0% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.19B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...